R, H. Monoclonal Antibody Therapy in Early Alzheimer’s disease: a Review of Lecanemab and Aducanumab. Biospecia, [S. l.], v. 2, n. 1, p. 1–6, 2026. Disponível em: https://uniquepubinternational.com/journals/index.php/biospecia/article/view/182. Acesso em: 22 apr. 2026.